{"id":"pemetrexe","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Fatigue/Asthenia","drugRate":"","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"","severity":"common","organSystem":""},{"effect":"Constipation","drugRate":"","severity":"common","organSystem":""},{"effect":"Vomiting","drugRate":"","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"","severity":"common","organSystem":""},{"effect":"Decreased Appetite/Anorexia","drugRate":"","severity":"common","organSystem":""},{"effect":"Rash","drugRate":"","severity":"common","organSystem":""},{"effect":"Cough","drugRate":"","severity":"common","organSystem":""},{"effect":"Dyspnea","drugRate":"","severity":"common","organSystem":""},{"effect":"Pyrexia","drugRate":"","severity":"common","organSystem":""},{"effect":"Neutropenia","drugRate":"","severity":"common","organSystem":""},{"effect":"Anemia","drugRate":"","severity":"common","organSystem":""},{"effect":"Stomatitis/Pharyngitis","drugRate":"","severity":"common","organSystem":""},{"effect":"Thrombocytopenia","drugRate":"","severity":"common","organSystem":""}],"contraindications":["Anemia","Breastfeeding (mother)","Concomitant yellow fever vaccine","Impaired renal function disorder","Kidney disease","Neutropenic disorder","Pregnancy, function","Thrombocytopenic disorder"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Acute Kidney Injury","drugRate":"3%","severity":"serious"},{"effect":"Pneumonitis","drugRate":"2%","severity":"serious"},{"effect":"Pneumonia","drugRate":"4%","severity":"serious"}]},"trials":[],"_chembl":{"chemblId":"CHEMBL2360464","moleculeType":"Small molecule","molecularWeight":"471.38"},"aliases":["Alimta"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"2308f4e8-21c8-49c1-a5b8-deb8610bac6a","title":"PEMFEXY (PEMETREXED) INJECTION [EAGLE PHARMACEUTICALS, INC.]"},"ecosystem":[],"mechanism":{"target":"Serine hydroxymethyltransferase, cytosolic, Folate receptor beta, Folate transporter 1"},"_scrapedAt":"2026-03-28T03:11:48.437Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Malignant mesothelioma of pleura","diseaseId":"malignant-mesothelioma-of-pleura","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Non-small cell lung cancer","diseaseId":"non-small-cell-lung-cancer","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03792503","phase":"PHASE4","title":"Pemetrexed Plus Apatinib Maintenance Treatment in Patients With Non-squamous Non-small Cell Lung Cancer Patients Who Have Not Progressed After 4 Cycles of Induction Chemotherapy of Pemetrexed in Combination With Platinum-based Regimen","status":"WITHDRAWN","sponsor":"Xinqiao Hospital of Chongqing","startDate":"2019-02","conditions":"Advanced Non-squamous Non-small-cell Lung Cancer","enrollment":""},{"nctId":"NCT03656393","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Gefitinib in Adjuvant Chemotherapy for Lung Adenocarcinoma","status":"UNKNOWN","sponsor":"Shenzhen People's Hospital","startDate":"2018-08-31","conditions":"NSCLC, EGFR","enrollment":48},{"nctId":"NCT01665417","phase":"PHASE4","title":"Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma","status":"UNKNOWN","sponsor":"Betta Pharmaceuticals Co., Ltd.","startDate":"2012-08","conditions":"EGFR Positive Non-small Cell Lung Cancer, Adenocarcinoma","enrollment":100},{"nctId":"NCT01985451","phase":"PHASE2","title":"Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma （PCNSL）","status":"UNKNOWN","sponsor":"Rongjie Tao","startDate":"2013-03","conditions":"Central Nervous System Tumors","enrollment":15}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Pemetrexe","genericName":"Pemetrexe","companyName":"Rongjie Tao","companyId":"rongjie-tao","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}